Search
Lixte Biotechnology Holdings Inc
LIXTAdd to Watchlist
7.210USD
-0.460-6.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
83.87MMarket Cap
LossP/E TTM
Lixte Biotechnology Holdings Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-1.26
21.24%
Analyst Rating
--
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Lixte Biotechnology Holdings Inc?
According to Lixte Biotechnology Holdings Inc's FY2025 earnings report, its current assets were 5.18M, with a year-on-year change of 352.06.
What are the total assets of Lixte Biotechnology Holdings Inc?
According to Lixte Biotechnology Holdings Inc's FY2025 earnings report, its total assets of Lixte Biotechnology Holdings Inc were 12.73M, with a year-on-year change of 1011.62.
What are the total liabilities of Lixte Biotechnology Holdings Inc?
According to Lixte Biotechnology Holdings Inc's FY2025 earnings report, its total liabilities of Lixte Biotechnology Holdings Inc were 1.77M, with a year-on-year change of 456.76.
What is the total equity of Lixte Biotechnology Holdings Inc?
According to Lixte Biotechnology Holdings Inc's FY2025 earnings report, its total equity of Lixte Biotechnology Holdings Inc was 10.96M, with a year-on-year change of 1225.11.
What is the Earnings Per Share (EPS) of Lixte Biotechnology Holdings Inc?
According to Lixte Biotechnology Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.26, with a year-on-year change of 21.24.
What is the Return on Assets (ROA) of Lixte Biotechnology Holdings Inc?
According to Lixte Biotechnology Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -86.60, with a year-on-year change of 34.14.
What is the operating profit of Lixte Biotechnology Holdings Inc?
According to Lixte Biotechnology Holdings Inc's FY2025 earnings report, its operating profit was -5.11M, with a year-on-year change of -42.96.